Furthermore, a small pilot RT-qPCR-based analysis confirmed a demarcated shift in expression profiles in CA724, CEA, RUNX1 and TIMP1 in IBD patients compared to CRC patients’ tissue samples. The gene discussed is CEACAM5; the disease is colorectal carcinoma.